Anika Therapeutics
ANIK
Reported
Thursday, October 31
Q3 2024 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | -0.01 | -0.25 | -0.24 | -2400.00% |
| Revenue | 42.1M | 38.8M | -3.33M | -7.91% |
WhatIF - Earnings
EPS Missed Expectations by -$0.24
Anika Therapeutics (ANIK:NASDAQ) has never missed EPS by this much before
There’s a first time for everything